Synthesize Bio
Seattle
About Synthesize Bio
Deep biomedical data is the key to unlocking discoveries and creating therapies. Synthesize Bio uses AI to reduce data collection and analysis from months to minutes for a fraction of the cost in time, personnel, and materials.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $10.0M
- Funding stage: Seed
- Last round: Seed (Sep 2025)
- Website: synthesize.bio
- Phone: +1 206 555 0123
Social Profiles
Canonical: https://fsome.com/organization/synthesize-bio-43570 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.